Dysexecutive Syndrome in a Patient with Wilson’s Disease


Clinical Case Report: This paper presents the alterations and deficits in executive functions of a 33 years old man with Wilson’s disease, patient at the Hospital Universitario La Samaritana in Bogotá, who in 2011 was diagnosed with cerebellar ataxia, and beginning to show a clinical picture of dysarthria and generalized motor difficulties. The presence of neuropsychological disorders, as well as the results obtained by Magnetic Resonance Imaging (MRI) of the brain and optical exam (Kayser-Fleischer rings) confirmed the diagnosis of Wilson’s disease. Results and Conclusion: The neuropsychological profile of the patient showed alterations of attention and mnemonic processes associated with frontal functioning, as well as slowing-down of motor activities and low speed in processing information. The assessment of executive functions revealed impairment in cognitive flexibility, impulsivity and disinhibition, as well as difficulties in the process of planning, organizing and monitoring. All of these features indicated the presence of a dysexecutive syndrome in the patient and correlated with the results obtained by MRI.

Share and Cite:

Gutiérrez-Ávila, N. , Zúñiga-Márquez, J. , Burgos-Torres, N. , Arias-Valencia, J. , Quintero-Cusguen, P. & Acosta-Barreto, R. (2014). Dysexecutive Syndrome in a Patient with Wilson’s Disease. Psychology, 5, 47-52. doi: 10.4236/psych.2014.51009.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Ardila, A. (2008). On the evolutionary origins of executive functions. Brain and Cognition, 68, 92-99.
[2] Ardila, A., & Ostrosky, F. (2012). Guía para el Diagnóstico Neuropsicológico. México D.F.: Universidad Nacional Autónoma de México.
[3] Bernal, D., & Calle, J. (2007). Aspectos neuropsiquiátricos de la enfermedad de Wilson y la esclerosis múltiple. Revista Colombiana de Psiquiatría, 36, 126-138.
[4] Bidaki, B., Zare, M., Mirhosseini, M., Moghadami, S., Hejrati, M., Kohnavard, M., & Shariati, B. (2012). El mal manejo de la enfermedad de wilson como trastorno psicótico. Advanced Biomedical Research, 1.
[5] Birk, L., Horn, N., Dysgaard, T., Vissing, J., Wibrand, F., Jennum, P., & Ott, P. (2011). Clinical presentation and mutations in danish patients with wilson disease. European Journal of Human Genetics, 19, 935-941. http://dx.doi.org/10.1038/ejhg.2011.80
[6] Carta, M., Sorbello, O., Moro, M., Bhat, K., Demelia, E., Serra, A., & Mura, G. (2012). Bipolar disorders and wilson. BMC Psychiatry, 12, 52. http://dx.doi.org/10.1186/1471-244X-12-52
[7] Carta, M., Mura, G., Sorbello, O., Farina, G., & Demelia, L. (2012). Quality of life and psychiatric symptoms in wilson’s disease: The relevance of bipolar disorders. Clinical Practice & Epidemiology in Mental Health, 8, 102-109.
[8] Castaneda, M., Ubilluz, R., ávalos, C., Escalante, D., & Nicoll, J. (2002). Enfermedad de wilson: forma nueropsiquiátrica dominante presentación de un caso y su interpretación fisiopatológica basada en resonancia magnética del encéfalo. Revista de Gastroenterología del Perú, 22, 74-80.
[9] Clark, Y., Collazo, T., Ruenes, C., & García, E. (2011). Detección de cambios conformacionales y mutaciones en el exón 8 del gen atp7b en pacientes cubanos con la enfermedad de wilson. Biotecnología Aplicada, 28, 83-86.
[10] Cheon, J., Kim, I., Seo, J. K., Ko, J. S., Lee, J. M., Shin, C., Kim, W. S., & Yeon, K. M. (2010). Clinical application of liver MR imaging in wilson’s disease. Korean Journal of Radiology, 11, 665-672.
[11] Di Stefano, V., Lionetti, E., Rotolo, N., La Rosa, M., & Leonardi, S. (2012). Hypercalciuria and nephrocalcinosis as early feature of wilson disease onset: Description of a pediatric case and literature review. International Monthly Journal in the field oh hepatology, 18, 1-4. http://dx.doi.org/10.5812/hepatmon.6233
[12] Elliott, R. (2013). Executive functions and their disorders. British Medical Bulletin, 65.
[13] European Association for the Study of the Liver (2012). Easl clinical practice guidelines: Wilson’s disease. Journal of Hepatology, 56, 671-685.
[14] Garrido, M., & Fernández, S. (2004). Déficit neuropsicológicos en alcohólicos: Implicaciones para la seguridad vial. Revista de Neurologia, 38, 277-283.
[15] Günther, P., Villmann, T., & Hermann, W. (2011). Event related potentials and cognitive evaluation in wilson. Journal of Neurological Sciences, 28, 79-85. http://www.jns.dergisi.org/text.php3?id=423
[16] Hegde, S., Sinha, S., Taly, A., & Vasudev, M. (2010). Cognitive profile and structural findings in wilson disease: A neuropsychological and MRI-based study. Neurol India, 58, 708-713.
[17] Hernández, R., Fernández, C., & Baptista, P. (2008). Metodología de la investigación (4th ed.). México, México: Mc Graw Hill.
[18] Hewlett, A. (2012). Handbook of liver disease (3rd ed., pp. 230-244).
[19] Hitoshi, S., Iwata, M., & Yoshikawa, K. (1991). Mid-brain pathology of wilson. Journal of Neurology, Neurosurgery, and Psychiatry, 54, 624-626. http://dx.doi.org/10.1136/jnnp.54.7.624
[20] Huster, D., Kühne, A., Bhattacharjee, A., Raines, L., Jantsch, V., Noe, J., Caca, K., & Lutsenko, S. (2012). Diverse functional properties of wilson disease atp7b variants. Gastroenterology, 142, 947-956.
[21] Jacob, R., & Srivatsa, V. (2011). Wilson’s disease presenting with psychosis. Asian Journal of Psychiatry, 4, 68-69.
[22] Krysiak, R., Handzlik-Orlik, G., & Okopien, B. (2012). Endocrine symptoms as the initial manifestation of wilson. The Yale Journal of Biology and Medicine, 85, 249-254.
[23] Lezak, M. D. (1995) Neuropsychological assessment. Nueva York: Oxford University Press.
[24] Levy, R., & Dubois, B. (2006). Apathy and the functional anatomy of the prefrontal cortex—Basal ganglia circuits. Cerebral Cortex, 16, 916-928. http://dx.doi.org/10.1093/cercor/bhj043
[25] Litwin, T., Gromadzka, G., Czlonkowska, A., Poniatowska, M., & Poniatowska, R. (2013). The effect of gender on brain MRI pathology in wilson’s disease. Springer US, 28, 69-75.
[26] Litwin, T., Gromadzka, G., Szpak, G., Salach, J., Bulska, E., & Czlonkowska, A. (2013). Brain metal accumulation in wilson. Journal of the Neurological Sciences, 329, 55-58.
[27] Litwin, T., Gromadzka , G., Grzywacz, A. Czlonkowska, A., Czlonkowska, A., Czlonkowski , J., & Samochowiec, J. (2012). Association of dopamine receptor gene polymorphisms with the clinical course of wilson disease, 73-80. http://dx.doi.org/10.1007/8904_2012_163
[28] López, M., & Serrano, M. (2007). Enfermedad de wilson: Reporte de un caso y revisión de la literatura. Medicina Interna de México, 23, 458-463.
[29] López, J., Serrano, I., Llano, J., Mateos, J., López, S., & Sánchez, M. (2010) Utilidad del test de Stroop en el trastorno por déficit de atención/hiperactividad. Revista Espanola de Neurología, 50, 333-340.
[30] Lorincz, M. T. (2010). Neurologic Wilson’s Ds, Lisease. Annals of New York Academic of Science, 1184, 173-187.
[31] Moller, L. B., Horn, N., Joppesen, T. D., Vissing, J., Wibrand, F., Jennum, P., & Ott, P. (2011). Clinical presentation and mutations in Danish patients with Wilson Disease. European Journal of Human Genetics, 19, 935-941. http://dx.doi.org/10.1038/ejhg.2011.80
[32] Nagel, J., & Miralles, S. (2007). Enfermedad de Wilson: Comienzo con síntomas psiquiátricos. Hallazgos en resonancia magnética encefálica. Revista Argentina de Radiología, 71, 45-49
[33] Peng, F., Lutsenko, S., Sun, X., & Muzik, O. (2012). Positron emission tomography of copper metabolism in the atp7b-/- knock-out mouse model of wilson’s disease. Molecular Imaging and Biology, 14, 70-78. http://dx.doi.org/10.1007/s11307-011-0476-4
[34] Pfeiffer, R. (2011). Handbook of clinical neurology, 100, 681-709.
[35] Pladdy, H. (2007). Dysexecutive syndromes in neurologic disease. JNPT, 31.
[36] Popevic, M., Kisic, G., Dukic, M., & Bulat, P. (2011). Work ability assessment in a patient with wilson’s disease. Archives of Industrial Hygiene and Toxicology, 62, 163-167.
[37] Posner, M. I., & Raichle, M. E. (1994). Images of mind. New York: Scientific American Library.
[38] Roberts, E. (2011). Wilson’s disease. Metabolic Liver Disease, 39, 602-604
[39] Scheres, A., Oosterlaan, J., Geurts, H., Morein-Zamir, S., Meiran, N., Schut, H., Vlasveld, L., & Sergeant, J. (2004). Executive functioning in boys with ADHD: Primarily an inhibition deficit? Archives of Clinical Neuropsychology, 19, 569-594.
[40] Schmitt de Bem, R., Araujo, D., Mitiko, M., Reis, E., Werneck, L., & Ghizoni, H. (2011). Wilson’s disease in southern Brazil: A 40-year follow-up study. Clinics, 66, 411-416.
[41] Stocco, A., Lebiere, C., & Anderson, J. (2010). Conditional routing of information to the cortex: A model of the basal ganglia’s role in cognitive coordination. Psychological Review, 117, 1-64.
[42] Suchy, Y. (2009). Executive functioning: Overview, assessment, and research issues for non-neuropsychologists. Annals of Behavioral Medicine, 37, 106-116.
[43] Svetel, M., Mijajlovi, M., Tomi, A., Kresojevi, N., Pekmezovi, T., & Kosti, V. (2012). Transcranial sonography in wilson’s disease. Parkinsonism and Related Disorders, 18, 234-238.
[44] Taly, A. B., Prashanth, L. K., & Sinha, S. (2009). Wilson’s Disease: An Indian pespective. Neurology India, 57, 528-540.
[45] Teive, H., De Bem, R., Muzillo, D., Deguti, M., Munhoz, R., & Barbosa, E. (2012). Wilson’s disease in the south of brazil: A 40 years follow-up study. Parkinsonism and Related Disorders, 18, S66.
[46] Verdejo-García, A., & Tirapu-Ustárroz, J. (2012). Neuropsicología clínica en perspectiva: Retos futuros basados en desarrollos presentes. Revista Neurología, 54, 180-186.
[47] Verdejo, A., & Bechara, A. (2010). Neuropsicologia de las funciones ejecutivas. Psicothetna, 22, 227-235.
[48] Verma, R., Patil, T., & Lalla, R. (2012). Acute extrapyramidal syndrome and seizures as heralding manifestation of Wilson disease. Neurology India, 60, 363-364.
[49] Wilson, B., Alderman, N., Burgess, P., Emslie, H., & Evans, J. (2003). Behavioural assessment of the dysexecutive syndrome (bads). Journal of Occupational Psychology, Employment and Disability, 5, 33-37.
[50] Xu, P., Lu, Z., Wang, X., Dosher, B., Zhou, J., Zhang, D., & Zhou, Y. (2010). Category and perceptual learning in subjects with treated Wilson’s disease. PLoS ONE, 5, Article ID: e9635.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.